Showing results (191-200 of 234) with videos related to

Sort By:
Pageof 24
Cancer Medicine|June 24, 2016
Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70-interacting protein in postmenopausal breast cancerSasagu Kurozumi, Yuri Yamaguchi, Shin-Ichi Hayashi, et al.
Breast Cancer (Tokyo, Japan)|October 19, 2015
APOBEC3B high expression status is associated with aggressive phenotype in Japanese breast cancersMiki Tsuboi, Arito Yamane, Jun Horiguchi, et al.
Theranostics|March 20, 2024
Cancer-associated fibroblast spatial heterogeneity and <i>EMILIN1</i> expression in the tumor microenvironment modulate TGF-β activity and CD8<sup>+</sup> T-cell infiltration in breast cancerChikako Kanno Honda, Sasagu Kurozumi, Takaaki Fujii, et al.
Molecular Oncology|November 23, 2019
RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesisHiroko Toda, Naohiko Seki, Sasagu Kurozumi, et al.
International Journal of Oncology|August 3, 2017
Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patientsSayaka Obayashi, Jun Horiguchi, Toru Higuchi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 17, 2010
Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndromeHideto Shinno, Yasunori Oka, Manabu Otsuki, et al.
Breast Cancer Research and Treatment|June 20, 2016
HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patientsSasagu Kurozumi, Mary Padilla, Masafumi Kurosumi, et al.
Anticancer Research|May 31, 2024
Significance of MUC1 and β-Catenin Localization in Mucinous Carcinoma of the BreastKei Sugawara-Komatsu, Takaaki Fujii, Sasagu Kurozumi, et al.
Frontiers in Psychiatry|October 7, 2017
Remission of Psychosis in Treatment-Resistant Schizophrenia following Bone Marrow Transplantation: A Case ReportTsuyoshi Miyaoka, Rei Wake, Sadayuki Hashioka, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 9, 2015
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, multicenter, double-blind, placebo-controlled trialTsuyoshi Miyaoka, Motohide Furuya, Jun Horiguchi, et al.
Pageof 24